Screening for Bladder and Urethra Cancer
An exclusive specialty
This is an effective and reliable new method of screening for bladder and urethra cancer in urine.
Together with urinary cytology, immunohistofluorescence (uCyt+) gives outstanding screening and diagnosis capability while providing excellent follow-up during treatment of the disease.
Bladder cancer is the second most prevalent urinary-tract cancer after prostate cancer. Bladder cancer is not a rare cancer, as it accounts for 3% of all cancers among adults around the age of 50. Although men are currently the most affected, this trend could be reversed due to the increasing number of women smokers.
Red-tinged urine is often the first warning sign. Even though this painless bleeding can go away, this doesn’t mean that the tumour has stopped growing. At a more advanced stage, other symptoms can appear, such as difficulty urinating, frequent micturation, a burning sensation and bladder pain.
Contact us for an appointment.
You must have a doctor’s prescription to use our private services.
Your private medical insurance can reimburse a minimum of 80% of your food allergy screening costs. Most allergy analyses results are available within five working days.